Oncology Partnerships EVERSANA Life Sciences has active oncology commercialization engagements, including participation in ASCO coverage, a collaboration with Candel Therapeutics for the US launch of CAN-2409, and a US launch support agreement with Xcovery for ENSACOVE. Alliance Life Sciences can be positioned as a specialized oncology commercialization partner within EVERSANA to support mid-sized biotech firms preparing US launches with services spanning market access, pricing, patient support, and channel strategy.

End-to-End Platform With an integrated global commercialization platform, Alliance Life Sciences can cross-sell end-to-end services to biotech and pharma clients seeking faster market entry. The mix of services including pricing, market access, marketing, patient support, channel distribution, and consulting, plus data overlays from Salesforce Health Cloud and Numerator supports differentiated offerings and faster time-to-revenue for clients.

Data Driven Insights Strong technology backbone including Salesforce Health Cloud, AWS EC2, NoSQL, Smartsheet and Numerator enables data-driven market access and payer strategies. Leveraging these tools, sales teams can position analytics-led pricing, access optimization, and real-world evidence generation as core differentiators for client wins and renewals.

Strategic Growth Momentum EVERSANA's growth momentum through partnerships and acquisitions — such as Waltz Health and ongoing oncology and immunotherapy collaborations — signals a compelling scale story for biotech teams seeking a robust commercialization partner. Alliance Life Sciences can ride this momentum to attract new clients by offering bundled capabilities and cross-border support across US and global markets.

Mid-Market Upsell Mid-market focus with a clear path to upsell into larger pharma accounts using EVERSANA’s broader platform. The ongoing governance enhancements and senior leadership appointments across EVERSANA strengthen regulatory and compliance support, presenting an opportunity to offer enhanced risk management and regulatory advisory services to risk-conscious clients.